Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,445.00
Bid: 1,449.00
Ask: 1,451.00
Change: 14.00 (0.98%)
Spread: 2.00 (0.138%)
Open: 1,449.00
High: 1,455.00
Low: 1,444.00
Prev. Close: 1,431.00
SMSN Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transactions with Affiliated Companies

30 Apr 2024 08:10

RNS Number : 5674M
Samsung Electronics Co. Ld
30 April 2024
 

Transaction with Affiliate Company

 

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024

announced that its Board of Directors has authorized following related-party transaction

with an affiliated company.

 

Trademark License Agreement

- Grant trademark license to Samsung Biologics

 

□ Major Transaction Terms

Transaction Item

License fee for use of trademark

Transaction Date

May 10, 2024

Transaction Period

February 1, 2024-January 31, 2027

Transaction Value

KRW 28,244 million

(total transaction value: KRW 28,244 million)

Other information

- The transaction date is the date on which the trademark license agreement with

 Samsung Biologics will be executed.

- Transaction period is the term of the trademark license agreement.

- The transaction value is an estimate and may change in accordance with

 Samsung Biologics revenue.

* The license fee is set at 0.5% of Samsung Biologics' revenue (excluding

revenue or purchases not related to the use of trademark) and shall be paid

every year during the transaction period.

Other Information:

ž Number of Independent Directors Present at the BOD Meeting: 6/6

ž Attendance of Audit Committee: Y

 

※ This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose

its financial and real estate transactions in the event the value of such a transaction is greater than or equal to

KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.

 

Transaction with Affiliate Company

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on April 30, 2024

announced that its Board of Directors has authorized following related-party transaction

with an affiliated company.

 

Trademark License Agreement

- Grant trademark license to Samsung Bioepis

 

□ Major Transaction Terms

Transaction Item

License fee for use of trademark

Transaction Date

May 10, 2024

Transaction Period

February 1, 2024 - January 31, 2027

Transaction Value

KRW 12,843 million

(total transaction value: KRW 12,843 million)

Other information

- The transaction date is the date on which the trademark license agreement with

 Samsung Bioepis will be executed.

- Transaction period is the term of the trademark license agreement.

- The transaction value is an estimate and may change in accordance with

 Samsung Bioepis revenue.

* The license fee is set at 0.5% of Samsung Bioepis' revenue (excluding

revenue or purchases not related to the use of trademark) and shall be paid

every year during the transaction period.

Other Information:

ž Number of Independent Directors Present at the BOD Meeting: 6/6

ž Attendance of Audit Committee: Y

 

※ This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose

its financial and real estate transactions in the event the value of such a transaction is greater than or equal to

KRW 10 billion and the counterparty is a financial affiliate of the party required to make the disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGFDNGRGDZG
Date   Source Headline
11th Apr 20237:00 amRNS1Q 2023 Pre-Earnings Guidance
15th Mar 202310:30 amRNSResults of the 54th Annual General Meeting
16th Feb 20237:49 amRNS2022 Separate Financial Statements
16th Feb 20237:45 amRNS2022 Consolidated Financial Statements
14th Feb 20239:25 amRNSReference Material for 2023 AGM
14th Feb 20239:16 amRNSTransaction with Affiliate Company
14th Feb 20239:06 amRNSTransaction with Affiliate Company
14th Feb 20239:03 amRNSCharitable Contribution
31st Jan 20237:05 amRNSTransaction with Affiliate Company
31st Jan 20237:04 amRNSAnnouncement of Capex Result for FY2022
31st Jan 20237:01 amRNSYear-End Dividend for FY2022
31st Jan 20237:00 amRNS2022 4Q Earning Release
6th Jan 20237:00 amRNSNotice of 4Q 2022 Earnings Release
6th Jan 20237:00 amRNS4Q 2022 Pre-Earnings Guidance
1st Dec 20227:39 amRNSCharitable Contribution
30th Nov 20227:55 amRNSTransactions with Affiliated Companies
30th Nov 20227:00 amRNS2022 3Q Interim Business Report
8th Nov 20227:55 amRNSAnnouncement of Investor Relations Event
3rd Nov 20228:03 amRNSCharitable Contribution
3rd Nov 20228:00 amRNSResults of the 54th Extraordinary General Meeting
27th Oct 20229:06 amRNSCharitable Contribution
27th Oct 20229:04 amRNSAnnouncement of Capex Plan for FY2022
27th Oct 20228:56 amRNSQuarterly Dividend for Third Quarter 2022
27th Oct 20228:49 amRNS2022 3Q Earnings Release
7th Oct 20227:00 amRNSNotice of 3Q 2022 Earnings Release
7th Oct 20227:00 amRNS3Q 2022 Pre-Earnings Guidance
5th Oct 20221:35 pmRNSReference Material for 2022 EGM
1st Sep 202210:46 amRNSRecord Date for Samsung Electronics' EGM
1st Sep 202210:44 amRNSNotice of Extraordinary General Meeting
31st Aug 20223:44 pmRNS2022 Half-year Business Report
28th Jul 20228:57 amRNSCharitable Contribution
28th Jul 20228:48 amRNSTransaction with Affiliate Company
28th Jul 20228:42 amRNSQuarterly Dividend for Second Quarter 2022
28th Jul 20228:35 amRNS2022 2Q Earnings Release
7th Jul 20227:56 amRNSNotice of 2Q 2022 Earnings Release
7th Jul 20227:55 amRNS2Q 2022 Pre-Earnings Guidance
30th Jun 202210:01 amRNSSustainability Report 2022
31st May 202211:43 amRNSCorporate Governance Report FY2021
31st May 202211:02 amRNS2022 1Q Interim Business Report
18th May 202210:26 amRNSEarly Termination of Independent Director’s Term
29th Apr 20222:50 pmRNS2021 Business Report
28th Apr 202210:01 amRNSTransactions with Affiliated Companies
28th Apr 20229:49 amRNSTransactions with Affiliated Companies
28th Apr 20229:44 amRNSCharitable Contribution
28th Apr 20229:29 amRNSQuarterly Dividend for First Quarter 2022
28th Apr 20229:24 amRNS2022 1Q Earnings Release
21st Apr 20229:18 amRNSEarly Termination of Independent Director’s Term
21st Apr 20228:49 amRNSEarly Termination of Independent Director’s Term
7th Apr 20229:35 amRNSNotice of 1Q 2022 Earnings Release Schedule
7th Apr 20229:32 amRNS1Q 2022 Pre-Earnings Guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.